Kayaş, Y. Et Al. 2018. Serum amyloid A and Lipoprotein Associated phospholipaseA2 levels in patients with malign melanoma:correlations with clinical assesment and stage. TÜRK DERMATOLOJİ DERGİSİ , vol.12 , 135-141.

Kayaş, Y., Girgin Sağın, F., Akçay, Y., Kocabaş, G., Azarsız, E., Sözmen, E., ... Özdemir, F.(2018). Serum amyloid A and Lipoprotein Associated phospholipaseA2 levels in patients with malign melanoma:correlations with clinical assesment and stage. TÜRK DERMATOLOJİ DERGİSİ , vol.12, 135-141.

Kayaş, Yavuz Et Al. "Serum amyloid A and Lipoprotein Associated phospholipaseA2 levels in patients with malign melanoma:correlations with clinical assesment and stage," TÜRK DERMATOLOJİ DERGİSİ , vol.12, 135-141, 2018

Kayaş, Yavuz Et Al. "Serum amyloid A and Lipoprotein Associated phospholipaseA2 levels in patients with malign melanoma:correlations with clinical assesment and stage." TÜRK DERMATOLOJİ DERGİSİ , vol.12, pp.135-141, 2018

Kayaş, Y. Et Al. (2018) . "Serum amyloid A and Lipoprotein Associated phospholipaseA2 levels in patients with malign melanoma:correlations with clinical assesment and stage." TÜRK DERMATOLOJİ DERGİSİ , vol.12, pp.135-141.

@article{article, author={Yavuz Kayaş Et Al. }, title={Serum amyloid A and Lipoprotein Associated phospholipaseA2 levels in patients with malign melanoma:correlations with clinical assesment and stage}, journal={TÜRK DERMATOLOJİ DERGİSİ}, year=2018, pages={135-141} }